Stomach cancer
Creating a new tool to predict side effects of chemotherapy in older patients with stomach and bowel cancers a study done at multiple hospitals
Who can joinAdults
Age60+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbai, MaharashtraDirections ↗
Registry summary (technical)
Development of a new prediction score (CARG-GI) for chemotherapy toxicity in older patients with gastrointestinal cancer- A multicenter, prospective study - CARG-GI
Sponsor: Tata Memorial Centre
CTRI/2025/10/096342 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 2 Mar 2026 · read by us 5 Nov 2026